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http:WHAT THIS PAPER ADDS
The relationship between vitamin D status and abdominal aortic aneurysm (AAA) has not been clearly deﬁned.
We conducted an observational study and found an inverse relationship between 25-hydroxyvitamin D (25(OH)
D) and the presence of AAA in community-dwelling older men. There is also a negative doseeresponse asso-
ciation between 25(OH)D and the size of AAA, suggesting a role of vitamin D in the severity of aneurysmal
arterial disease. To our knowledge, this is the ﬁrst study to demonstrate an independent relationship between
hypovitaminosis D with the presence and size of AAA in older men.
Further research is needed to clarify the mechanisms underlying these associations.Objective: This study aims to investigate the association between plasma 25-hydroxyvitamin D (25(OH)D)
concentrations with the presence of abdominal aortic aneurysm (AAA) and aortic diameter.
Design: An observational study of 4233 community-dwelling men aged 70e88 years, who participated in
a randomised controlled trial of screening for AAA.
Methods: Infrarenal aortic diameter measured by ultrasound and 25(OH)D by immunoassay.
Results: A total of 311 men (7.4%) with AAA (deﬁned as aortic diameter 30 mm) comprised the study.
Multivariable models were adjusted for age, smoking, cardiovascular disease, hypertension, diabetes,
dyslipidaemia, body mass index and serum creatinine concentration. Amongst men with the lowest 25(OH)D
quartile of values compared with the highest quartile, the adjusted odds ratio of having an AAA increased in
a graded fashion from 1.23 (95% conﬁdence interval (CI) 0.87e1.73) for AAA30 mm to 5.42 (95% CI 1.85e15.88)
for AAA40 mm. Similarly, there was a doseeresponse relationship between 25(OH)D concentrations and the size
of the AAA: every 10-nmol l1 decrease in 25(OH)D levels was associated with 0.49 mm (95% CI 0.11e0.87)
increase in mean aortic diameter.
Conclusions: Low vitamin D status is associated with the presence of larger AAA in older men, and there is
a graded inverse relationship between 25(OH)D concentrations and AAA diameter. Further research is needed to
clarify the mechanisms underlying these associations.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Article history: Received 6 December 2012, Accepted 14 March 2013, Available online 19 April 2013
Keywords: Vitamin D, Abdominal aortic aneurysm, Aortic diameter, Arterial diseaserresponding author. Y.Y.E. Wong, Western Australian Centre for
& Ageing (WACHA), University of Western Australia (M573), Royal
ospital, Level 6, Ainslie House, 48 Murray Street, Perth, Western
ia 6000, Australia. PO Box address: University of Western Australia
), Box X2213, Perth, Australia 6847. Tel.: þ61 8 9224 8440; fax: þ61
8009.
il address: ewong@meddent.uwa.edu.au (Y.Y.E. Wong).
-5884/$ e see front matter  2013 European Society for Vascular
. Published by Elsevier Ltd. All rights reserved.
//dx.doi.org/10.1016/j.ejvs.2013.03.015Vitamin D and its metabolites are known to have signiﬁcant
roles in the maintenance of calcium and bone homeostasis. In
recent years, they have also been extensively researched for
their pleiotropic effects on biological processes other than
skeletal health. Epidemiological studies have suggested that
hypovitaminosis D might be a contributory factor to cardio-
vascular disease (CVD) including ischaemic heart disease,
peripheral arterial disease (PAD) and stroke.1 It is also linked
to major traditional CVD risk factors, such as hypertension,
dyslipidaemia and obesity,2 as well as CVD mortality.3
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effects include endothelial dysfunction, inﬂammation,
reduced vessel compliance, detrimental effects via bone
proteins such as osteoprotegerin as well as dysregulation of
the renineangiotensin system.4e8 On the other hand,
a recent systematic review and meta-analysis of vitamin D
intervention trials failed to demonstrate a signiﬁcant reduc-
tion in CVD events with vitamin D supplementation, thus
implying that hypovitaminosis D might be an epiphenom-
enon, rather than as an aetiological factor for CVD.9
Aneurysmal arterial disease is pathologically charac-
terised by extensive disruption of the extracellular matrix
with the loss of medial elastin and consequent reduction in
tensile strength.10 This results in vascular wall weakening
and progressive localised dilatation. Abdominal aortic
aneurysm (AAA) and occlusive CVD share many risk factors,
including age, male gender, genetic predisposition, smoking,
hypertension, hypercholesterolaemia and obesity.11,12 As
AAA is also independently associated with a higher risk of
incident CVD events and mortality, it has been traditionally
considered as a manifestation of atherosclerosis.13
However, there are important differences between aneu-
rysmal and occlusive CVD suggesting disparate pathogen-
esis. The most notable difference is the inverse association
between diabetes and AAA.14
Vitamin D inﬂuences a range of molecular pathways of
potential relevance to the pathogenesis of AAA.15 As the
relationship between vitamin D status and AAA is unknown,
we sought to determine whether there is any relationship
between plasma concentration of vitamin D and both the
presence and diameter of AAA. This was undertaken in
a large cohort of men aged 70e88 years.SUBJECTS AND METHODS
Study design and participants
We conducted a cross-sectional observational study of
participants from the Health in Men Study (HIMS), which
has been described in detail elsewhere.16,17 In brief,
approximately 40,000 men aged 65e83 years were rando-
mised to the screening and control arms of the trial of
screening for AAA. A total of 12,203 men participated in
screening and completed a health assessment between
1996 and 1999 (HIMS Wave 1). In 2001e2004, 5585 men
responded to the second phase of this study (HIMS Wave 2)
and blood samples were collected from 4249 of them. The
Human Research Ethics Committee of the University of
Western Australia approved the protocol for HIMS and
informed consent was obtained from the participants.Outcome of interest
The abdominal aortic diameter was measured during HIMS
Wave 1. The greatest transverse and antero-posterior
diameter of the infrarenal aorta was measured using
a Toshiba Capasee ultrasound machine with a 3.75-MHz
probe (Toshiba Australia, North Ryde, New South Wales,
Australia). The reproducibility of these ultrasoundmeasurements has been previously reported.18 An AAA was
considered present if the abdominal aortic diameter was
30 mm or greater.Explanatory variables
Using a combination of data collected at Waves 1 and 2, the
following variables were available: age, smoking status
(current, former or never smoker during Wave 2), physical
activity (150 min of moderate-to-vigorous exercise in
a usual week during Wave 1), CVD (self-reported history of
angina, myocardial infarction, heart failure, coronary artery
bypass grafting, coronary angioplasty, carotid endarterec-
tomy, aortic bypass surgery, peripheral arterial surgery or
stroke during Wave 1 or 2), hypertension (self-reported
diagnosis, or use of anti-hypertensive medications or
measured average blood pressure > 140/90 mmHg), dia-
betes (self-reported diagnosis, or use of glucose-lowering
medication, or a fasting glucose of 7 mmol l1 or non-
fasting glucose 11 mmol l1) and dyslipidaemia (self-re-
ported diagnosis, or use of lipid-lowering medication, or
fasting low-density lipoprotein 3.4 mmol l1, high-density
lipoprotein <0.9 mmol l1, triglycerides 1.8 mmol l1 or
total cholesterol 5.5 mmol l1). Height, weight and waist
circumference were measured during Wave 2 in accordance
with guidelines of the International Society for the
Advancement of Kinanthropometry.19 Body mass index
(BMI) was calculated from height and weight in kg me2.Validation of CVD variables
In addition to data from the questionnaire, the Western
Australian Data Linkage System (WADLS)20 was used to
identify men with any admissions to hospital for CVD by the
end of Wave 2 screening. This system links together data
from the state cancer registry, death registry and hospital
morbidity data system. The admissions were identiﬁed using
the relevant diagnoses and procedure codes from the
International Classiﬁcation of Diseases (ICD). The predictive
utility of CVD for all-cause mortality was tested in our
cohort by using mortality records up to 31 December 2010.Biochemical analyses
Blood samples were collected during Wave 2 between 0800
and 1030. Plasma was separated from the blood samples
within 1 h of collection and stored at 80 C until assayed.
Plasma 25-hydroxyvitamin D [25(OH)D], an established
marker of vitamin D status, was measured using the auto-
mated DiaSorin ‘LIAISON 25(OH)D TOTAL’ chemilumines-
cent immunoassay, which was carried out on archived
serum in a series of runs performed between 2011 and
2012. The interassay coefﬁcient of variation was 13.2% at
37.9 nmol l1 and 11.3% at 131 nmol l1. Serum high-
sensitivity C-reactive protein (hsCRP) was measured with
assay on a BNII analyser (Dade Behring, Birmingham, UK).
Serum creatinine, glucose, cholesterol, low-density lipo-
protein and triglycerides were measured with a Roche
Hitachi 917 analyser (Roche Diagnostics, Basel, Switzerland).
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Data were analysed using Stata release 11.1 (Stata Corp,
College Station, TX, USA). Descriptive statistics were calcu-
lated for the demographic, lifestyle and clinical variables
according to the presence or absence of AAA. A Cox
proportional hazards model was used to test the association
between CVD and mortality. Adjustments were made for
age, smoking, hypertension, diabetes, dyslipidaemia, BMI
and creatinine. The association between 25(OH)D and AAA
was investigated in three different ways: according to
25(OH)D quartiles of values (using the highest quartile as
reference), per 10-nmol l1 decrease in 25(OH)D concen-
tration and by halving of 25(OH)D concentration (by
dividing the natural logarithm of 25(OH)D by the natural
logarithm of 0.5). To investigate the relationship between
25(OH)D with the presence of AAA, logistic regression
analyses were performed with 25(OH)D modelled as
continuous and categorical variables. The associations were
explored for the presence of any AAA (aortic diameter
30 mm) and larger AAAs (diameter 35 mm and
40 mm, respectively). To determine the relationship
between 25(OH)D and aortic diameter, linear regression
was used with the aortic diameter modelled as a contin-
uous variable in aneurysmal (aortic diameter 30 mm) and
non-aneurysmal (<30 mm) ranges. Adjustments were made
for age, smoking, CVD, diabetes, hypertension, dyslipidae-
mia, BMI and serum creatinine as potential confounders.
The results were reported as odds ratios (ORs) with 95%
conﬁdence intervals (95% CI). P-values <0.05 were
considered statistically signiﬁcant.
RESULTS
A ﬂow chart detailing disposition of the study participants is
shown in Fig. 1. Men who had died prior to theWave 2 follow-
up or did not attend due to various reasons were older in
age (P < 0.001), more likely to be smokers (P < 0.001) and
self-report a history of CVD (P ¼ 0.025), hypertension
(P < 0.001) and diabetes (P < 0.001) during Wave 1, in
comparison to those men who subsequently responded in
Wave 2. The demographic, clinical and biochemical charac-
teristics of men with and without AAA are shown in Table 1. A
total of 4233 men, aged 70e88 years, had complete data for
25(OH)D levels, aortic diameter and co-morbidities. The mean
(standard deviation (SD)) 25(OH)D concentration for the
cohort was 68.3  23.3 nmol l1 and the quartiles of values
correspond to 10.0e52.8 (median 42.3), 52.9e67.3 (median
60.3), 67.4e81.6 (median 73.8) and 81.7e238.4 nmol l1
(median 93.7 nmol l1), respectively. As many as 311 men
(7.4%) had an AAA (aortic diameter 30 mm), 120 men
(2.8%) had AAA 35 mm and 66 men (1.6%) had AAA
40 mm.The mean (SD) aortic diameter for the cohort was
22.8  4.9 mm (range 15.9e79.2 mm).
Predictive utility of CVD for all-cause mortality
In the multivariable Cox proportional hazards model, CVD
predicted all-cause mortality (hazard ratio (HR) 1.53, 95% CI
1.36e1.73).Association of 25(OH)D with AAA
In multivariable logistic regression analysis (Table 2), the
adjusted OR of having an AAA for men with the lowest 25(OH)
D quartile of values compared with the highest quartile was
1.23 (95% CI 0.87e1.73). This association became statistically
signiﬁcant and stronger in a graded fashion for larger AAAs,
with anORof 2.02 (95%CI 1.13e3.61) for AAA35mmandan
OR of 5.42 (95% CI 1.85e15.88) for AAA 40 mm. When
25(OH)D was modelled as continuous variables, there was
a graded increase in associationwith larger AAAs: for every 10-
nmol l1 decrease in 25(OH)D concentration, the odds were
increased by 14% (OR 1.14, 95% CI 1.04e1.24) for having AAA
35 mm and by 23% (OR 1.23, 95% CI 1.08e1.39) for having
AAA 40 mm. Fig. 2 demonstrates the OR of having an AAA
40 mm with changing 25(OH)D levels.Association of 25(OH)D with aortic diameter
We explored the association of 25(OH)D with abdominal
aortic diameter by stratifying the aortic diameter into aneu-
rysmal (30 mm) and non-aneurysmal (<30 mm) ranges
(Table 3). Adjustments were made for age, smoking, CVD,
hypertension, diabetes, dyslipidaemia, BMI and serum
creatinine. There was no statistically signiﬁcant association
between 25(OH)D and aortic diameters in the non-
aneurysmal range. For men with aortic diameters 30 mm,
every 10-nmol l1 decrease in 25(OH)D concentration was
associated with 0.49 (95% CI 0.11e0.87) increase in mean
aortic diameter. For those men with the lowest 25(OH)D
quartile of values compared with the highest quartile, there
was an associated 3.06 (95% CI 0.70e5.41) increment in
aortic diameter. The associations between 25(OH)D and
aortic diameter in the aneurysmal range persisted when
aortic diameter was log-transformed. Every 10-nmol l1
decrease in 25(OH)D concentration was associated with
0.01 mm (95% CI 0.00e0.02) increase in log-transformed
aortic diameter. For those men with the lowest 25(OH)D
quartile of values compared with the highest quartile, there
was an associated 0.08 mm (95% CI 0.02e0.13) increment in
log-transformed aortic diameter.Subgroup analyses
Vitamin D supplementation might inﬂuence 25(OH)D
concentration and these data were available at the Wave 2
assessment. Ten men with AAA and 90 men without AAA
had reported taking these supplements (P ¼ 0.303). We
performed a sensitivity analysis of the association between
25(OH)D and AAA by excluding men taking supplements.
The effect estimate for the presence of an AAA in men with
the lowest 25(OH)D quartile of values compared with the
highest quartile was not signiﬁcantly affected (OR 1.18, 95%
CI 0.84e1.67). For AAA 35 mm and AAA 40 mm,
the ORs were 1.95 (95% CI 1.08e3.50) and 5.56 (95% CI
1.90e16.32), respectively. Additional adjustments for
physical activity, waist circumference and hsCRP also did not
appreciably alter the association of 25(OH)D with AAA (data
not shown).
Study flow diagram of Health In Men Study (HIMS)
19352 men were invited to participate in HIMS 
12203 men attended clinic and completed Wave 1 questionaire in 1996-1999 
4263 men attended clinic and completed Wave 2 questionaire in 2001-2004; 
1322 men completed Wave 2 questionaire by postage only; 
4249 of the above had blood samples collected from them; 
4233 men had complete data for 25-hydroxyvitamin D concentrations, aortic diameter 
and comorbidities 
456 men were excluded from study: 
- Previous scan or operation for 
abdominal aortic aneurysm 
(n=328) 
- < 65 years of age (n=118) 
- Could not scan aorta (n=10) 
5200 men were unable to attend, 
unwell, untraceable or did not respond 
Men aged 65 years and older were randomly selected from electoral roll (N=49801)
8801 men lived too far away 
from screening clinic;  
2296 men died before 
randomisation 
38704 men were randomised 
19352 men were randomised as 
Control group: no contact were 
made and these men were 
followed up via record linkage 
6693 men were unable to attend, unwell, 
untraceable or did not respond 
10940 men were invited to follow-up study 
1263 men died before invitation to 
follow-up
155 men died after invitation 
Figure 1. Study ﬂow diagram of Health in Men Study (HIMS).
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regression models, the odds of having an AAA in men with
the lowest 25(OH)D quartile of values compared with the
highest quartile was 1.27 (95% CI 0.90e1.81). For AAA
35 mm and AAA 40 mm, the ORs were 1.92 (95% CI
1.07e3.47) and 4.69 (95% CI 1.59e13.85), respectively. For
blood samples collected during the summer/autumn and
winter/spring calendar periods, the lowest quartile of
25(OH)D values corresponded to 58.8 and 48.0 nmol l1,
respectively. When multivariable logistic regression analysis
was performed using 25(OH)D collected during summer/
autumn, the odds of having an AAA in men with the lowest
25(OH)D quartile of values compared with the highest
quartile was 1.27 (95% CI 0.88e1.83). When this was
repeated for 25(OH)D collected during winter/spring, the
OR remained similar (OR 1.25, 95% CI 0.90e1.73). When
the analyses were repeated for AAA 35 and AAA 40 mmstratiﬁed by the season of blood sample collection, the
associations persisted.DISCUSSION
In this population-based sample of older men, there is an
association between low 25(OH)D concentration and the
presence of larger AAA, which is independent of traditional
cardiovascular risk factors, and occurs in a graded fashion
with increasing sizes of AAA. In men with AAA, 25(OH)D
concentration is also inversely correlated with abdominal
aortic diameter in a doseeresponse relationship.
The strengths of this study include the large sample size
of well-characterised, population-based community-
dwelling older men. Measurement of the aortic diameter
was performed in a standardised procedure using ultra-
sound. We were able to comprehensively adjust for
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Figure 2. Odds ratio of an abdominal aortic aneurysm 40 mm
with changing serum 25-hydroxyvitamin D [25(OH)D] levels.
25(OH)D are entered into the models as restricted cubic splines (3
knots) with a reference value of 93.7 nmol/l (median value of the
highest quartile). The 25(OH)D scale of 30e110 nmol/l relates to
the range between 5th and 95th percentiles of values (n ¼ 3810).
Dashed lines denote 95% conﬁdence interval.
Table 1. Demographic, lifestyle and clinical characteristics of the
study population according to the presence or absence of
abdominal aortic aneurysm (AAA).
AAA No AAA P value
(n ¼ 311) (n ¼ 3922)
Age, yearsa 77.7 (3.6) 76.5 (3.6) <0.001
Smoking, n(%)
Current smoker 37 (11.9) 178 (4.5) <0.001
Former smoker 234 (75.5) 2371 (60.5)
Never smoked 39 (12.6) 1373 (35.0)
Physical activity, n(%) 56 (18.0) 901 (23.0) 0.044
Cardiovascular
disease, n(%)
182 (58.5) 1165 (29.7) <0.001
Diabetes, n(%) 67 (21.5) 596 (15.2) 0.003
Hypertension, n(%) 247 (79.7) 2971 (77.1) 0.292
Dyslipidemia, n(%) 255 (82.0) 2773 (69.7) <0.001
BMI, kg/m2a 27.0 (3.8) 26.5 (3.6) 0.010
Waist circumference,
cma
101.8 (10.6) 99.0 (10.0) <0.001
Aortic diameter, mma 36.2 (7.5) 21.8 (2.6) <0.001
25(OH)D, nmol/la 65.0 (22.8) 68.6 (23.3) 0.010
hsCRP, mg/la 4.9 (8.5) 3.7 (7.3) 0.007
Creatinine, mmol/la 104.8 (40.9) 92.9 (30.7) <0.001
Abbreviations: BMI, body mass index; 25(OH)D, 25-hydroxyvitamin
D; hsCRP, high-sensitivity C-reactive protein.
a Mean (SD).
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including age, smoking, CVD and risk factors that have
established associations with both vitamin D status and AAA
development. We acknowledge several limitations in this
study. The observational design of our current study and the
fact that blood samples were obtained from the partici-
pants several years (5.7  0.9 years) after baseline aortic
diameter measurements preclude determination of
causality over time. We did not have data on calcium or
parathyroid hormone, which can inﬂuence vitamin D
metabolism. Aortic diameters in our cohort were likely to
have increased by a small margin between the period of
baseline measurement and blood sampling.21 However, we
have assumed in this study that the small number of
interval cases of AAA would not have substantially altered
the results or introduced any bias. Those men who had
responded for assessment during Wave 2 were younger inTable 2. Multivariable logistic regression modelsb evaluating the ass
abdominal aortic aneurysm (AAA) in community-dwelling older men.
AAA 30 mm (n ¼ 311) AAA
Or 95% CI Or
25(OH)Da 1.03 0.98 to 1.09 1.14
Halving of 25(OH)D 1.16 0.92 to 1.44 1.60
25(OH)D quartile 1 1.23 0.87 to 1.73 2.02
25(OH)D quartile 2 0.84 0.58 to 1.22 1.90
25(OH)D quartile 3 1.20 0.85 to 1.70 1.41
25(OH)D quartile 4 1.00 1.00
Abbreviations: OR, odds ratio; 95% CI, 95% conﬁdence interval.The qu
(median 42.7 nmol/l), 52.9e67.3 (median 60.3 nmol/l), 67.4e81.6
93.7 nmol/l), respectively.
a Odds ratio per 10-nmol/l decrease in 25(OH)D concentration.
b Adjusted for age, smoking, cardiovascular disease, hypertension, dysage (P < 0.001), more physically active (P < 0.001) and had
less self-reported co-morbidities (P < 0.001) during Wave 1
compared to the non-respondents of the follow-up study.
The self-selection of participants suggests a possible
‘healthy survivor’ effect, which might have biased our
ﬁndings towards higher 25(OH)D concentrations in our
cohort compared to the non-respondents. This could have
moved the results of our study towards a null hypothesis
and led to an underestimation of the association between
low 25(OH)D with AAA. Our ﬁndings were therefore
conservative. The study was limited to men and we were
therefore unable to generalise our ﬁndings to women,
although the prevalence of AAA is about ﬁve times greater
in men than women.12 To our knowledge, this is the ﬁrst
study to demonstrate an independent relationship between
low vitamin D status with the presence and size of AAA in
older men. Van de Luijtgaarden et al. have recently reported
on the vitamin D status in 236 patients with either thoracic
or abdominal aneurysm.22 Although 9.7% of these patients
with aortic aneurysm had vitamin D levels 25 nmol l1ociation of 25-hydroxyvitamin D [25(OH)D] with the presence of
35 mm (n ¼ 120) AAA 40 mm (n ¼ 66)
95% CI Or 95% CI
1.04 to 1.24 1.23 1.08 to 1.39
1.15 to 2.23 1.97 1.28 to 3.02
1.13 to 3.61 5.42 1.85 to 15.88
1.06 to 3.42 4.96 1.68 to 14.62
0.75 to 2.63 3.85 1.26 to 11.77
1.00
artiles for 25(OH)D corresponded to values of: 10.0e52.8 nmol/l
nmol/l (median 73.8 nmol/l) and 81.7e238.4 nmol/l (median
lipidemia, diabetes, body mass index and serum creatinine.
Table 3. Linear regression models evaluating the association of 25-hydroxyvitamin D [25(OH)D] with abdominal aortic diameter in
aneurysmal and non-aneurysmal ranges in community-dwelling older men.
Aortic diameter < 30 mm Aortic diameter 30 mm
Crude mean (95% CI) Adjustedb mean (95% CI) Crude mean (95% CI) Adjustedb mean (95% CI)
25(OH)Da 0.01 (0.04 to 0.03) 0.03 (0.07 to 0.00) 0.58 (0.22e0.94) 0.49 (0.11e0.87)
Halving of 25(OH)D 0.03 (0.18 to 0.12) 0.13 (0.28 to 0.03) 2.00 (0.53e3.47) 1.77 (0.20e3.35)
25(OH)D quartile 1 0.09 (0.32 to 0.13) 0.19 (0.42 to 0.04) 3.75 (1.47e6.03) 3.06 (0.70e5.41)
25(OH)D quartile 2 0.05 (0.17e0.28) 0.03 (0.26 to 0.19) 4.55 (2.06e7.03) 4.22 (1.69e6.76)
25(OH)D quartile 3 0.03 (0.26 to 0.19) 0.09 (0.32 to 0.13) 2.13 (0.24e4.50) 2.01 (0.38e4.40)
25(OH)D quartile 4 1.00 1.00 1.00 1.00
Abbreviation: 95% CI, 95% conﬁdence interval.The quartiles for 25(OH)D corresponded to values of: 10.0e52.8 nmol/l (median 42.7 nmol/
l), 52.9e67.3 (median 60.3 nmol/l), 67.4e81.6 nmol/l (median 73.8 nmol/l) and 81.7e238.4 nmol/l (median 93.7 nmol/l), respectively.
a Regression coefﬁcient per 10-nmol/l decrease in 25(OH)D concentration.
b Adjusted for age, smoking, cardiovascular disease, hypertension, diabetes, dyslipidemia, body mass index and serum creatinine.
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combining of patients with thoracic and abdominal aneu-
rysms make this study inconclusive with regard to the
strength and independence of any association between
vitamin D status and AAA presence and size.22 Several
previous studies have attempted to explore the relationship
between vitamin D status and vascular integrity, which is
conceivably impaired in AAA.23 AAA is characterised by
reduced elastin concentration relative to collagen in the
aortic wall,12 also considered to be the pathophysiology in
arterial stiffness with reduced vascular compliance.24
Previous observational studies have associated low
vitamin D status with increased arterial stiffness.5,25e28
Other clinical studies have also reported on the observed
association between 25(OH)D and PAD, an alternative
model of vascular disease which shares a similar yet distinct
pathogenesis with AAA.1,29e33 Our results extend these
ﬁndings and further support the relevance of vitamin D to
large artery disease in humans.
In experimental studies, 1,25(OH)D binds to the vitamin D
receptor and modulates the expression of multiple proteins
relevant to the arterial wall, including vascular endothelial
growth factor (VEGF) and matrix metalloproteinase type 9
(MMP-9).15 Vitamin D exerts vasoprotective effects through
the inhibition of VEGF-induced endothelial cell proliferation,
the anti-proliferative effect on vascular smooth muscle cells
(VSMCs) and the suppression of angiogenesis via induction of
apoptosis.34,35 It also modulates the inﬂammatory cascade
by inhibiting the production of pro-inﬂammatory cytokines
(interleukin-6 and interleukin-8) and the expression of
adhesion molecules in human arterial endothelial cells, both
of which processes are normally regulated by the activation
of nuclear transcription factor-kB (NF-kB) through the
induction of tumour necrosis factor alpha (TNF-a).36 Finally,
vitamin D plays a fundamental immune-modulating role by
augmenting T-helper 2 cell responses via selective cytokine
production, a condition that predominates in AAA
formation.37,38
Our prevalence of AAA was 7.4%, which was relatively high
in comparison to thosederived fromother largeAAA screening
programmes.39 There are a number of possible reasons: men
aged up to 83 years, rather than the usual 65e74 years, were
included in our study (aortic diameter increases with age), andthe fact that measurement of aortic diameter was performed
using ‘outer to outer’ wall (this gives the largest possible
diameter).The relatively lower proportions of larger AAAsmay
be explained by these cases being offered surgery prior to the
blood-testing phase of the study. The inverse relationship
between diabetes and AAA has been widely reported, albeit
inconclusively, due to statistically non-signiﬁcant ﬁndings in
some studies.40 Althoughwehave found a positive association
betweenAAAand thepresenceofdiabetes by the endofWave
2 screening, a previous analysis using data inWave 1 reported
an inverse correlation between serum glucose and aortic
diameter in non-diabetic men.14 Despite demonstrating
seasonal variation in plasma 25(OH)D concentrations, this has
not altered the association between low vitamin D status and
the presence of larger AAA in our cohort of older men.
In conclusion, we have found an inverse relationship
between vitamin D status and the presence of larger AAA,
irrespective of traditional CVD and associated risk burden,
in community-dwelling older men. There is also an inverse
doseeresponse association between 25(OH)D concentra-
tions and the size of AAA, suggesting a role of vitamin D in
the severity of aneurysmal arterial disease. Further research
is needed to clarify the mechanisms underlying these
associations and to explore the feasibility of interventional
studies with abdominal aortic diameter as an ‘end’ point.
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